Nvidia Corp is close to a deal to buy British chip designer Arm Holdings from SoftBank Group Corp for more than US$40 billion (£31.26 billion) in a deal which would create a giant in the chip industry, according to two people familiar with the matter.
NEW YORK: Facebook has started removing false claims that the deadly wildfires in Oregon were started by various left-wing and right-wing groups, a spokesman for the social media company said on Saturday (Sep 12), after the rumours left state officials inundated with queries for information. Since ...
SEOUL: In June 2013, a seven-member boyband released its first music video No More Dream. The track reached the heady heights of #84 on the South Korean government-sponsored Gaon Music Chart. Six years on, BTS would become just the third group in 50 years to have three number one...
It is a question on the minds of couples looking to buy their first home: Pull out all the stops for your dream home or get something cheaper? Dawn Cher lays out her view.
SoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than US$40 billion, the Wall Street Journal reported https://on.wsj.com/2Rlv7HC on Saturday, citing sources.
Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than US$20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter.
U.S. Gulf of Mexico oil producers on Saturday evacuated offshore facilities as a tropical storm brewing off the Florida coast was forecast to strengthen into a hurricane and threaten the prime oil region.
SoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than US$40 billion, the Wall Street Journal reported https://on.wsj.com/2Rlv7HC on Saturday, citing sources.
SoftBank Group Corp is nearing a deal to sell British chip designer Arm Holdings to Nvidia Corp for more than US$40 billion, the Wall Street Journal reported https://on.wsj.com/2Rlv7HC on Saturday, citing sources.
British clinical trials for the AstraZeneca and Oxford University coronavirus vaccine have resumed following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so, the company said on Saturday.
